Literature DB >> 33454343

Closing Gaps in Lifestyle Adherence for Secondary Prevention of Coronary Heart Disease.

Monica Aggarwal1, Dean Ornish2, Richard Josephson3, Todd M Brown4, Robert J Ostfeld5, Neil Gordon6, Shivank Madan5, Kathleen Allen7, Aditya Khetan3, Ahmed Mahmoud1, Andrew M Freeman8, Karen Aspry9.   

Abstract

The secondary prevention (SP) of coronary heart disease (CHD) has become a major public health and economic burden worldwide. In the United States, the prevalence of CHD has risen to 18 million, the incidence of recurrent myocardial infarctions (MI) remains high, and related healthcare costs are projected to double by 2035. In the last decade, practice guidelines and performance measures for the SP of CHD have increasingly emphasized evidence-based lifestyle (LS) interventions, including healthy dietary patterns, regular exercise, smoking cessation, weight management, depression screening, and enrollment in cardiac rehabilitation. However, data show large gaps in adherence to healthy LS behaviors and low rates of enrollment in cardiac rehabilitation in patients with established CHD. These gaps may be related, since behavior change interventions have not been well integrated into traditional ambulatory care models in the United States. The chronic care model, an evidence-based practice framework that incorporates clinical decision support, self-management support, team-care delivery and other strategies for delivering chronic care is well suited for both chronic CHD management and prevention interventions, including those related to behavior change. This article reviews the evidence base for LS interventions for the SP of CHD, discusses current gaps in adherence, and presents strategies for closing these gaps via evidence-based and emerging interventions that are conceptually aligned with the elements of the chronic care model.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Year:  2021        PMID: 33454343     DOI: 10.1016/j.amjcard.2021.01.005

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.

Authors:  S Störk; P U Heuschmann; K Ungethüm; S Wiedmann; M Wagner; R Leyh; G Ertl; S Frantz; T Geisler; W Karmann; R Prondzinsky; C Herdeg; M Noutsias; T Ludwig; J Käs; B Klocke; J Krapp; D Wood; K Kotseva
Journal:  Clin Res Cardiol       Date:  2022-09-27       Impact factor: 6.138

2.  Correlation Analysis Between Required Surgical Indexes and Complications in Patients With Coronary Heart Disease.

Authors:  Meiyi Tao; Xiaoling Yao; Shengli Sun; Yuelan Qin; Dandan Li; Juan Wu; Yican Xiong; Zhiyu Teng; Yunfei Zeng; Zuoheng Luo
Journal:  Front Surg       Date:  2022-07-06

3.  Findings and lessons learnt implementing a cardiovascular disease quality improvement program in Australian primary care: a mixed method evaluation.

Authors:  C M Hespe; K Giskes; M F Harris; D Peiris
Journal:  BMC Health Serv Res       Date:  2022-01-26       Impact factor: 2.655

Review 4.  Intimate Relationships and Coronary Heart Disease: Implications for Risk, Prevention, and Patient Management.

Authors:  Timothy W Smith
Journal:  Curr Cardiol Rep       Date:  2022-04-05       Impact factor: 3.955

5.  Development of a Digital Lifestyle Modification Intervention for Use after Transient Ischaemic Attack or Minor Stroke: A Person-Based Approach.

Authors:  Neil Heron; Seán R O'Connor; Frank Kee; David R Thompson; Neil Anderson; David Cutting; Margaret E Cupples; Michael Donnelly
Journal:  Int J Environ Res Public Health       Date:  2021-05-02       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.